211 related articles for article (PubMed ID: 37632203)
21. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
22. Radiation effects on antitumor immune responses: current perspectives and challenges.
Walle T; Martinez Monge R; Cerwenka A; Ajona D; Melero I; Lecanda F
Ther Adv Med Oncol; 2018; 10():1758834017742575. PubMed ID: 29383033
[TBL] [Abstract][Full Text] [Related]
23. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
[TBL] [Abstract][Full Text] [Related]
24. Abscopal effect in the radio and immunotherapy.
Pevzner AM; Tsyganov MM; Ibragimova MK; Litvyakov NV
Radiat Oncol J; 2021 Dec; 39(4):247-253. PubMed ID: 34986545
[TBL] [Abstract][Full Text] [Related]
25. [Abscopal effect: Myth or reality?].
Mirjolet C; Truc G
Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
[TBL] [Abstract][Full Text] [Related]
26. Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges.
Goto T
Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31455032
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation.
Hoopes PJ; Wagner RJ; Duval K; Kang K; Gladstone DJ; Moodie KL; Crary-Burney M; Ariaspulido H; Veliz FA; Steinmetz NF; Fiering SN
Mol Pharm; 2018 Sep; 15(9):3717-3722. PubMed ID: 29613803
[TBL] [Abstract][Full Text] [Related]
28. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
29. Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
Levy A; Chargari C; Marabelle A; Perfettini JL; Magné N; Deutsch E
Eur J Cancer; 2016 Jul; 62():36-45. PubMed ID: 27200491
[TBL] [Abstract][Full Text] [Related]
30. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
[TBL] [Abstract][Full Text] [Related]
31. Barriers to Radiation-Induced
Wennerberg E; Lhuillier C; Vanpouille-Box C; Pilones KA; García-Martínez E; Rudqvist NP; Formenti SC; Demaria S
Front Immunol; 2017; 8():229. PubMed ID: 28348554
[TBL] [Abstract][Full Text] [Related]
32. Improved cancer immunotherapy strategies by nanomedicine.
Guo S; Feng J; Li Z; Yang S; Qiu X; Xu Y; Shen Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1873. PubMed ID: 36576112
[TBL] [Abstract][Full Text] [Related]
33. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
34. Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment.
Ishihara D; Pop L; Takeshima T; Iyengar P; Hannan R
Cancer Immunol Immunother; 2017 Mar; 66(3):281-298. PubMed ID: 27743027
[TBL] [Abstract][Full Text] [Related]
35. Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations.
Johnsrud AJ; Jenkins SV; Jamshidi-Parsian A; Quick CM; Galhardo EP; Dings RPM; Vang KB; Narayanasamy G; Makhoul I; Griffin RJ
Radiat Res; 2020 Dec; 194(6):688-697. PubMed ID: 33348372
[TBL] [Abstract][Full Text] [Related]
36. Radiation therapy and immunotherapy-a potential combination in cancer treatment.
Asna N; Livoff A; Batash R; Debbi R; Schaffer P; Rivkind T; Schaffer M
Curr Oncol; 2018 Oct; 25(5):e454-e460. PubMed ID: 30464697
[TBL] [Abstract][Full Text] [Related]
37. Systemic Effects of Radiation Therapy-Induced Abscopal Responses in Patients with Advanced Lung Cancer.
D'Andrea MA; Reddy GK
Oncology; 2021; 99(1):1-14. PubMed ID: 33221794
[TBL] [Abstract][Full Text] [Related]
38. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
Caetano MS; Younes AI; Barsoumian HB; Quigley M; Menon H; Gao C; Spires T; Reilly TP; Cadena AP; Cushman TR; Schoenhals JE; Li A; Nguyen QN; Cortez MA; Welsh JW
Clin Cancer Res; 2019 Dec; 25(24):7576-7584. PubMed ID: 31540976
[TBL] [Abstract][Full Text] [Related]
39. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon-A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence.
Mireștean CC; Iancu RI; Iancu DT
Curr Oncol; 2022 Oct; 29(10):7388-7395. PubMed ID: 36290857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
